Breaking AI & Tech News Analyzed

Deontay Wilder survived a relentless challenge from 42‑year‑old Derek Chisora to claim a split‑decision win at the O2 Arena, London, on April 5, 2026. The bout, billed as Chisora’s 50th professional fight and farewell, unfolded as a high‑octane slugfest that many are already dubbing a fight‑of‑the‑year contender.Wilder opened the contest displaying the power that once made him a feared puncher, but Chisora responded with aggressive pressure, landing an early uppercut that sent both men teetering over the ropes. The second round mirrored the first, with Chisora’s forward thrust met by a slick combination from Wilder.Mid‑fight drama escalated when Chisora was knocked down in the eighth round. He beat the count and, despite a point deduction for Wilder later in the bout, rallied to force the American onto the ropes, showcasing remarkable resilience.The judges’ cards read 115‑111, 112‑115, and 115‑113 in favour of Wilder, delivering him a split‑decision triumph. The narrow margin underscores how closely contested the encounter was, keeping Chisora in the conversation for future heavyweight match‑ups.Adding to the night’s spectacle, former champion Anthony Joshua made a surprise appearance, greeting Chisora on his way to the ring – his first public outing since a December 2025 car crash that claimed two close friends.Throughout the ten‑round battle, both fighters exchanged knock‑downs and near‑knockouts. Wilder was deducted a point for a foul, while Chisora survived two knock‑downs without being stopped, earning a hero’s reception from the crowd during his final three minutes.While the arena roared for the last three minutes of Chisora’s career, the referee never intervened, allowing the British veteran to exit the ring to a standing ovation, marking an emotional close to a storied tenure in heavyweight boxing.

Peptides are short chains of amino acids that naturally occur in the body, acting as hormones such as insulin, oxytocin and vasopressin, or as fragments released during protein digestion.In recent years, a wave of interest has turned these molecules into purported therapeutic agents for everything from weight loss to anti‑ageing and tissue repair. Prescription drugs like semaglutide (Wegovy) and tirzepatide (Mounjaro) are synthetic peptides that have undergone rigorous clinical testing and are approved for specific medical uses.However, a large portion of the market consists of unregulated, experimental peptides sold for self‑administration. These products often bypass the strict approval processes required for medicines, raising serious safety concerns.Who is using these products? Initially confined to a niche of powerlifters and bodybuilders in the 2010s, the audience has expanded dramatically. Influential figures such as podcaster Joe Rogan have promoted combinations like the “Wolverine stack” (BPC‑157 and TB‑500) for injury recovery, while other compounds—CJC‑1295, MK‑677, ipamorelin, and GHK‑Cu—are marketed for muscle growth and anti‑ageing. Social media platforms are now flooded with instructions on purchasing and injecting these substances.Scientific backing is scant. Reviews of the literature reveal that most experimental peptides have only been tested in animal or cell models. For example, BPC‑157 shows promise for tendon and muscle repair in pre‑clinical studies, but no randomized human trials have validated these effects. Similarly, TB‑4 and its synthetic analogue TB‑500 have demonstrated limited blood‑vessel formation in laboratory settings, yet human data are absent and both are listed as prohibited substances by the World Anti‑Doping Agency.Researchers also highlight a critical knowledge gap: dosage, frequency and treatment duration remain undefined, making self‑administration a gamble.Legal landscape in the UK is clear that peptides not classified as medicines fall outside the Medicines and Healthcare products Regulatory Agency’s (MHRA) remit. If a seller makes medicinal claims, the product must hold a marketing authorisation under the Human Medicines Regulations 2012. The MHRA warns that labeling items as “research use only” does not shield vendors from enforcement when evidence shows the products are intended for human consumption.Health risks are multi‑fold. Experts caution that benefits observed in animal studies do not guarantee safety in humans. Contamination with harmful impurities or bacterial endotoxins can trigger severe reactions, including septic shock. Injecting excess natural peptides may disrupt the body’s tightly regulated hormonal balance, potentially affecting multiple physiological pathways.There is also theoretical concern that augmenting peptide levels could accelerate tumour growth, as some cancers over‑express certain peptide pathways. While no direct cases have been documented, the possibility underscores the need for caution.Additional dangers include improper injection techniques (e.g., air embolism), unknown interactions with existing medications, and the lack of systematic monitoring of long‑term effects. As one researcher put it, “If something goes wrong, users may never notice until irreversible damage has occurred.”

The prospect of a historic quadruple for Arsenal has evaporated. After a Carabao Cup final loss and a humbling defeat to second‑tier Southampton, the Gunners now face only two competitions.In a dramatic FA Cup quarter‑final, a late goal by Shea Charles clinched a 2‑1 win for the Saints, who have been reshaped by manager Tonda Eckert from relegation candidates into promotion frontrunners within six months.Southampton opened the scoring eleven minutes before halftime when Ross Stewart capitalised on a defensive lapse, slipping a low finish past Arsenal keeper Kepa Arrizabalaga. The lead was restored shortly after when substitute Viktor Gyökeres headed home, leveling the match.However, the decisive moment arrived in the 84th minute. After a swift build‑up involving Tom Fellows, Charles received the ball inside the box and calmly placed it past the keeper, sending the Saints into the FA Cup semi‑finals at the end of the month.The victory marks only the fifth occasion this season that a team has beaten the Premier League leaders, underscoring Southampton’s resurgence. The club also honoured its 50‑year FA Cup triumph with a special yellow‑and‑blue kit, recalling Bobby Stokes' winning goal in 1976.For Arsenal, the defeat compounds recent setbacks. Manager Mikel Arteta now has less than 48 hours before the team departs for Lisbon to face Sporting CP in the Champions League quarter‑final first leg, followed by a crucial Premier League clash at Manchester City.Despite the loss, Arsenal showed flashes of life, with Gyökeres equalising and a flurry of chances in stoppage time, but Southampton’s disciplined defence and Charles’ composure proved decisive.

Real Mallorca delivered a stunning upset to Real Madrid, winning 2‑1 thanks to an added‑time strike from Vedat Muriqi. The victory pushes the champions to four points behind Barcelona ahead of their upcoming clash with Atlético Madrid.The match began with Mallorca absorbing early pressure; goalkeeper Leo Román denied Kylian Mbappé twice with diving saves. Mallorca took the lead in the 42nd minute when Manu Morlanes headed home a cross from Pablo Maffeo.Real responded late, with Éder Militão—returning from a hamstring injury—equalising in the 88th minute. Just three minutes later, Muriqi, the league’s second‑highest scorer behind Mbappé, netted the winner, marking Mallorca’s first triumph over Real in three years and lifting them two points above the relegation zone.Muriqi, who had faced criticism after Kosovo’s World Cup qualifying loss, broke down in tears after the final whistle, saying, "Sometimes emotions get the better of you… I’m just happy to repay the supporters, we want to stay in this division for them."In Germany, Bayern Munich staged a dramatic comeback, scoring three goals in the final nine minutes to edge Freiburg 3‑2. Tom Bischof equalised, and Lennart Karl clinched the winner in stoppage time, despite the absence of injured striker Harry Kane. Bayern now travel to Real Madrid for their Champions League quarter‑final first leg.Freiburg had opened the scoring early in the second half with a long‑range strike from Johan Manzambi, and later doubled the lead via a Lucas Hoeler volley after a corner error by Manuel Neuer. However, Bayern’s late surge erased the deficit.Meanwhile, Borussia Dortmund secured a 2‑0 away win at VfB Stuttgart with late goals from Karim Adeyemi and Julian Brandt. The victory keeps Dortmund in second place on 64 points, nine behind Bayern, while Stuttgart slips to fourth.In Italy, Massimiliano Allegri of AC Milan reiterated his focus on the club, dismissing any immediate interest in the vacant Italy national team manager role after Gennaro Gattuso stepped down following a World Cup playoff defeat.

Mary Beth Hurt died on 28 March 2026 at the age of 79, closing a four‑decade career that blended intellectual cinema with acclaimed stage work. Born in Marshalltown, Iowa, she entered the film world with Woody Allen’s experimental drama Interiors (1978), earning a BAFTA nomination for Best Newcomer alongside Christopher Reeve.Although Interiors was a modest critical success, it proved financially profitable, grossing $10 million on a $3 million budget. Hurt’s portrayal of the directionless Joey marked the start of a career defined by thoughtful, understated performances.Her next high‑profile role came as Helen Holm, the college‑professor wife of Robin Williams’s titular character in The World According to Garp (1982). The film’s daring tonal shifts – including a shocking car‑crash scene – earned Oscar nominations for John Lithgow and Glenn Close, while giving Hurt a rare chance to play a fully sexual woman.Early setbacks included losing the lead in Joan Micklin Silver’s Head Over Heels (1979) to Jamie Lee Curtis and a troubled turn in the melodrama A Change of Seasons (1980), which suffered from production turmoil and poor box‑office returns.On stage, Hurt distinguished herself with three Tony nominations: for Pinero’s Trelawny of the ‘Wells’ (1976) opposite a debuting Meryl Streep, for a 1982 revival of Beth Henley’s Crimes of the Heart, and for Michael Frayn’s Benefactors (1986). She debuted on Broadway in 1974’s revival of William Congreve’s Love For Love opposite Glenn Close.Her personal life intersected with her professional world. She married fellow actor William Hurt in 1971, divorcing in December 1982, and later wed director Paul Schrader in August 1983. Collaborations with Schrader included Light Sleeper (1992), Affliction (1997) and The Walker (2007).Later film work featured a supporting turn in Karen Moncrieff’s feminist thriller The Dead Girl (2006), which earned her an Independent Spirit Award nomination, and a cameo in Martin Scorsese’s The Age of Innocence (1993). Her final screen appearance was in the small‑town drama Change in the Air (2018), filmed before a diagnosis of Alzheimer’s disease.Reflecting on her craft, Hurt once said, "I never felt very beautiful or incredibly smart or witty, so I was always looking for something about the role that intrigued me… more fascinating than the gold‑medal moments."She is survived by husband Paul Schrader and their two children, Molly and Sam.

AI‑Driven Power Race The AI boom is prompting the biggest wave of power‑infrastructure investment since the early days of cloud computing. Companies are scrambling to lock in natural‑gas supplies and build on‑site generators, a move that could reshape electricity markets in the southern United States. Scale of the Projects Microsoft is partnering with Chevron and Engine No. 1 to construct a natural‑gas plant in West Texas that could reach 5 GW of capacity. Google has confirmed a collaboration with Crusoe for a 933 MW plant in North Texas. Meta is adding seven more plants to its Hyperion data‑center complex in Louisiana, bringing total on‑site capacity to 7.46 GW—enough, the company notes, to power the entire state of South Dakota. Combined, these projects exceed 13 GW, roughly equivalent to the average electricity demand of a mid‑size U.S. state. Supply Constraints and Cost Pressures Wood Mackenzie warns that turbine prices have surged 195% versus 2019 levels. If a 2020 turbine cost $1 million, the same unit now costs about $2.95 million, inflating the equipment share of a plant’s budget from 20% to up to 30%. The consultancy also notes a six‑year lead time for turbine delivery, meaning new orders cannot be placed until 2028. This bottleneck could delay the rollout of additional capacity precisely when AI workloads are accelerating. Resource Availability and Market Risks The U.S. Geological Survey estimates that a single gas‑rich region holds enough supply to power the entire United States for 10 months. While abundant, production growth in the three leading shale basins—responsible for three‑quarters of U.S. output—has slowed, tightening the long‑term outlook. Natural gas accounts for about 40% of U.S. electricity generation (EIA). Consequently, any spike in gas prices reverberates through wholesale electricity markets, raising the cost of power for all consumers, not just data‑center operators. Strategic Risks for Tech Companies Behind‑the‑meter gas plants allow firms to claim “self‑supply,” but they merely shift demand from the public grid to the gas grid, potentially driving up wholesale gas prices. Industrial users—petrochemical plants, fertilizer manufacturers—cannot easily substitute gas with renewables, so they may push back against large‑scale data‑center consumption. Extreme weather, such as the 2021 Texas freeze, can curtail wellhead output, forcing a choice between keeping AI workloads online or supplying heat to households. In sum, the AI‑driven rush for natural‑gas power plants highlights a fundamental physical constraint: the digital economy still depends on finite, market‑sensitive energy resources. Betting heavily on a commodity that can swing dramatically in price may prove costly if AI growth plateaus or if gas supply tightens.

The Shift from Silent Infrastructure to Political FlashpointFor years, data centers operated as the silent backbone of the digital economy, largely unnoticed by the communities they served. However, recent polling data suggests this era of quiet expansion is ending. A growing wave of local opposition is turning data centers into a contentious political issue, forcing tech companies to confront the reality that their infrastructure is no longer welcome in everyone's backyard.Discrepancies in Public Sentiment: Harvard/MIT vs. QuinnipiacThe debate is split, with conflicting data highlighting the complexity of public opinion. A Harvard/MIT poll conducted in November offers a moderate view, finding that 40% of respondents supported the construction of a data center in their area. However, this support drops significantly when compared to industrial facilities, with 32% opposing the idea.Harvard/MIT Poll (Nov): 40% support data centers; 32% oppose.Quinnipiac Poll (March): 65% oppose AI data centers; 24% support.A fascinating insight from the Axios report notes that public preference shifts dramatically based on the facility type: more people would rather have an e-commerce warehouse than a data center.The Economic Trade-off: Jobs vs. Power CostsThe core of the conflict lies in the perceived benefits and drawbacks of these facilities. While data centers promise economic growth, a significant portion of the population is skeptical. Two-thirds of respondents in the Harvard/MIT survey expressed concern that a new data center would nudge electricity prices higher.Conversely, e-commerce warehouses are viewed more favorably, likely due to the tangible promise of local jobs and economic stimulation. However, analysts warn that this sentiment may be short-lived, as most data center projects employ very few people once operational, unlike the labor-intensive nature of warehousing.From Local Zoning to National Policy: The Future of Data Center RegulationThe divergence in polling numbers—from the moderate 40% support to the sharp 65% opposition—suggests that the data center debate is far from settled. As these facilities continue to proliferate, the discontent is likely to spill over into politics.With the "quiet" era of data center expansion effectively over, we can expect a surge in local zoning battles and potential federal regulation aimed at managing the energy consumption and community impact of AI infrastructure.

Wrexham pulled off a stunning comeback to draw 2-2 against West Brom, significantly boosting their chances of securing a Championship playoff spot. The match saw Isaac Price's deflected free-kick and Josh Maja's penalty give West Brom a strong lead heading into halftime.However, Wrexham mounted an impressive second-half recovery. Josh Windass scored a spectacular goal from 20 yards just two minutes after the restart, and Lewis O'Brien and George Dobson were involved in a controversy that led to an own goal, leveling the score for Wrexham.This draw propels Wrexham into sixth place, just a point above Southampton, who have a game in hand. The two teams are set to face each other in north Wales on Tuesday in a crucial matchup.In other matches, Hull drew 1-1 at Oxford, with Mo Belloumi scoring early in his return from injury. Leicester came from behind to draw 2-2 against Preston, with Patson Daka scoring twice after returning from international duty.Blackburn secured a vital 1-0 win over Birmingham thanks to Todd Cantwell's 69th-minute goal, moving six points clear of the relegation zone. Portsmouth boosted their survival hopes with a 1-1 draw at Norwich, while QPR beat Watford 2-1.In a thrilling match, Swansea came from two goals down to draw 3-3 at Sheffield United. Stoke secured a comfortable 2-0 victory over already-relegated Sheffield Wednesday, extending their unbeaten home run to five matches.

A federal judge has dismissed 10 out of 13 claims made by Blake Lively against director Justin Baldoni, including allegations of sexual harassment, conspiracy, and defamation. The lawsuit, which centers around the filming of 'It Ends With Us,' a domestic abuse drama where Lively and Baldoni starred as characters with intimate scenes, will proceed to trial next month on claims of a retaliatory campaign against Lively.Baldoni's lawyer, Bryan Freedman, described the defendants as 'very good people who have not engaged in this sexual harassment as alleged.' He expressed satisfaction with the court's ruling, stating it confirms what his legal team believed from the start.The judge's 152-page opinion emphasized that Lively's claims must be viewed in the context of the film's production, noting that creative artists need space to experiment within scripted scenes without fear of liability for sexual harassment. The court also determined Lively was working as an independent contractor, not an employee, which impacted her ability to bring sexual harassment claims.Lively's attorney, Mike Gottlieb, responded that the ruling was based on 'legal technicalities' and not an endorsement of the defendants' conduct. A trial is scheduled for May 18.